7ACB

Covalent/noncovalent tetramer of Capra hircus Cathelicidin-1 in DPC (dodecylphosphocholine) micelles

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	0.336 mM Capra hircus Cathelicidin-1 (dodecylphosphocholine), 1.6 % [U-99% 2H] DPC	95% H2O/5% D2O	0.01 mM	4.0	AMBIENT Pa	313	Bruker AVANCE III 600
2	2D 1H-1H TOCSY	0.336 mM Capra hircus Cathelicidin-1 (dodecylphosphocholine), 1.6 % [U-99% 2H] DPC	95% H2O/5% D2O	0.01 mM	4.0	AMBIENT Pa	313	Bruker AVANCE III 600
3	2D 1H-15N HSQC	0.96 mM 15 Capra hircus Cathelicidin-1, 1.6 % [U-99% 2H] DPC	95% H2O/5% D2O	0.01 mM	4.0	AMBIENT Pa	313	Bruker AVANCE III 800
5	3D 1H-15N NOESY	0.96 mM 15 Capra hircus Cathelicidin-1, 1.6 % [U-99% 2H] DPC	95% H2O/5% D2O	0.01 mM	4.0	AMBIENT Pa	313	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800
3	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
2	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
3	collection	TopSpin		Bruker Biospin
4	chemical shift assignment	CARA		Keller and Wuthrich
5	peak picking	CARA		Keller and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.